Brain Stem Evoked Auditory Response In Hypertension

Aim: To Assess the involvement of Peripheral and Central Brainstem Auditory Pathways in Hypertension Patients Materials & Methods: Eligibility Criteria for Hypertension Patients in the Study: BP > 140/90 mmHg, as per JNC 7 Guidelines, and Under Control with Antihypertensive Medications. Subjects with Acute Illness were excluded. Informed Written Consent Acquisition. Informed Written Consent Acquisition in the Study was made to Ensure Ethical Participation. Exclusion Criteria and Instrumentation in the Study: Patients with associated diseases (e.g., Diabetes Mellitus, Ischemic Heart Disease, Cerebrovascular Disease) or auditory abnormalities were excluded. Medicaid Neuroperfect plus Instrument was utilized, and electrodes were placed following the 10-20 international system of EEG electrode placement. The parameters include: Absolute latency of all the waves from I to V Interpeak latency I-III, I-V and III-V Result: The results of the study indicate that the Absolute Latency of Wave I in the hypertensive group showed a statistically significant prolongation, with a P value of 0.0001. This suggests that there is a notable delay in the auditory nerve response in these individuals compared to the control group. The statistically significant prolongation observed in the latency values of Waves I, V, Inter-peak latency I-V, and Inter-peak latency III-V highlights the impact of hypertension on auditory function and warrants further investigation for a better understanding of the underlying mechanisms. Conclusion: These findings indicate that there are measurable delays in the auditory nerve responses and the conduction of auditory signals along the brainstem pathways in individuals with hypertension. Further research in this area may help to better understand the underlying mechanisms and potentially explore novel approaches for managing auditory abnormalities in hypertensive patients.